Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+regulatory T-cell function and FOXP3 expression-Reference-Cited by-同舟云学术

Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+regulatory T-cell function and FOXP3 expression

Published:2006-06 Issue:8 Volume:83 Page:1432-1446
ISSN:0360-4012
Container-title:Journal of Neuroscience Research
language:en
Short-container-title:J. Neurosci. Res.

Author:

Venken Koen,Hellings Niels,Hensen Karen,Rummens Jean-Luc,Medaer Robert,D'hooghe Marie B.,Dubois Bénédicte,Raus Jef,Stinissen Piet

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference41 articles.

1. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation;Asseman;J Exp Med,1999

2. CD4+CD25high regulatory cells in human peripheral blood;Baecher-Allan;J Immunol,2001

3. Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis;Balandina;Blood,2005

4. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism;Dai;J Clin Invest,2004

5. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis;de Kleer;J Immunol,2004

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving regulatory T cell production through mechanosensing;Journal of Biomedical Materials Research Part A;2024-03-07

2. A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing–remitting multiple sclerosis;Journal of Neurology;2023-05-28

3. Decreased frequency of regulatory T cells and level of helios gene expression in secondary progressive multiple sclerosis patients: Evidence about the development of multiple sclerosis;International Immunopharmacology;2023-03

4. Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis;Multiple Sclerosis Journal;2023-01-22

5. Immunopathology of multiple sclerosis;Translational Neuroimmunology, Volume 8;2023